158 related articles for article (PubMed ID: 19531455)
21. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Akeboshi M; Yamakado K; Nakatsuka A; Hataji O; Taguchi O; Takao M; Takeda K
J Vasc Interv Radiol; 2004 May; 15(5):463-70. PubMed ID: 15126656
[TBL] [Abstract][Full Text] [Related]
23. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness.
Iguchi T; Hiraki T; Gobara H; Mimura H; Fujiwara H; Tajiri N; Sakurai J; Yasui K; Date H; Kanazawa S
J Vasc Interv Radiol; 2007 Jun; 18(6):733-40. PubMed ID: 17538135
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.
Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T
Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525
[TBL] [Abstract][Full Text] [Related]
27. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer--a preliminary report of 33 patients.
Belfiore G; Moggio G; Tedeschi E; Greco M; Cioffi R; Cincotti F; Rossi R
AJR Am J Roentgenol; 2004 Oct; 183(4):1003-11. PubMed ID: 15385294
[TBL] [Abstract][Full Text] [Related]
28. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study.
Liu H; Steinke K
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):466-74. PubMed ID: 23870347
[TBL] [Abstract][Full Text] [Related]
29. Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients.
Palussière J; Italiano A; Descat E; Ferron S; Cornélis F; Avril A; Brouste V; Bui BN
Ann Surg Oncol; 2011 Dec; 18(13):3771-7. PubMed ID: 21638099
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience.
Fanucchi O; Ambrogi MC; Aprile V; Cioni R; Cappelli C; Melfi F; Massimetti G; Mussi A
Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):57-64. PubMed ID: 27059068
[TBL] [Abstract][Full Text] [Related]
31. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA).
Nour-Eldin NA; Exner S; Al-Subhi M; Naguib NNN; Kaltenbach B; Roman A; Vogl TJ
Int J Hyperthermia; 2017 Nov; 33(7):820-829. PubMed ID: 28540791
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term.
Ambrogi MC; Lucchi M; Dini P; Melfi F; Fontanini G; Faviana P; Fanucchi O; Mussi A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):177-83. PubMed ID: 16723242
[TBL] [Abstract][Full Text] [Related]
33. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.
Jin GY; Lee JM; Lee YC; Han YM; Lim YS
AJR Am J Roentgenol; 2004 Oct; 183(4):1013-20. PubMed ID: 15385295
[TBL] [Abstract][Full Text] [Related]
34. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
35. Local progression after radiofrequency ablation for pulmonary metastases.
von Meyenfeldt EM; Prevoo W; Peyrot D; Lai A Fat N; Burgers SJ; Wouters MW; Klomp HM
Cancer; 2011 Aug; 117(16):3781-7. PubMed ID: 21319158
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation for single lung tumours not suitable for surgery: seven years' experience.
Carrafiello G; Mangini M; Fontana F; Laganà D; Cotta E; Di Massa A; Piacentino F; Ianniello A; Floridi C; Ierardi AM; Fugazzola C
Radiol Med; 2012 Dec; 117(8):1320-32. PubMed ID: 22744353
[TBL] [Abstract][Full Text] [Related]
37. [Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review].
Vogl TJ; Straub R; Lehnert T; Eichler K; Lüder-Lühr T; Peters J; Zangos S; Söllner O; Mack M
Rofo; 2004 Nov; 176(11):1658-66. PubMed ID: 15497085
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Tract Embolization After Percutaneous Pulmonary Radiofrequency Ablation.
Dassa M; Izaaryene J; Daidj N; Piana G
Cardiovasc Intervent Radiol; 2021 Jun; 44(6):903-910. PubMed ID: 33492452
[TBL] [Abstract][Full Text] [Related]
40. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A
Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
